Assembly Biosciences Reports Interim Phase 1a Data from Clinical Study of Oral Entry Inhibitor Candidate ABI-6250 for Hepatitis Delta Virus

Related posts

• INSP NEWS: Inspire Medical Systems, Inc. Sued for Securities Fraud after Stock Plummets 32% — Investors Notified to Contact BFA Law by January 5 Deadline

  December 3, 2025 GlobeNewswire 0

  INSP NEWS: Inspire Medical Systems, Inc. Sued for Securities Fraud after Stock Plummets 32% — Investors Notified to Contact BFA Law by January 5 Deadline

  Source: Medical

  Medical 

• Junction Brain Health Opens Toledo Clinic

  December 1, 2025 GlobeNewswire 0

  Junction Brain Health Opens Toledo Clinic

  Source: Medical

  Medical 

• INSP LEGAL ALERT: Inspire Medical Systems, Inc. Hit with Securities Fraud Class Action due to Product Delays — Investors Notified to Contact BFA Law by January 5

  December 1, 2025 GlobeNewswire 0

  INSP LEGAL ALERT: Inspire Medical Systems, Inc. Hit with Securities Fraud Class Action due to Product Delays — Investors Notified to Contact BFA Law by January 5

  Source: Medical

  Medical